An evaluation of 6 placebo-controlled clinical trials with 1,134 full contributors concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) have been linked to a better common improvement on the Ashworth scale for spasticity in various sclerosis clients when compared with placebo, Despite the fact that this did not attain statistical importance. https://andersonu517mha6.theisblog.com/profile